Impact of splenectomy on circulating microparticles in patients with sickle cell anemia.
hemoglobin F
hydroxyurea
microparticles
sickle cell anemia
spleen
Journal
International journal of laboratory hematology
ISSN: 1751-553X
Titre abrégé: Int J Lab Hematol
Pays: England
ID NLM: 101300213
Informations de publication
Date de publication:
03 Sep 2023
03 Sep 2023
Historique:
received:
21
12
2022
accepted:
14
07
2023
medline:
4
9
2023
pubmed:
4
9
2023
entrez:
4
9
2023
Statut:
aheadofprint
Résumé
Circulating microparticles (MP) are being described as potential biomarkers for disease activity in a variety of conditions including sickle cell anemia (SCA). However, relatively little is known about the influence of spleen status on MP levels in patients with SCA. Using a prospective study design we characterize circulating MP in 144 patients with SCA in steady state by assessing their cellular origin and their relationships to spleen status defined by clinical and imaging findings. In addition, MP levels were studied according to demographic characteristics, clinical status, treatment modalities, and other hematological and biochemical parameters. Absolute plasma concentrations of MP were determined by flow cytometry. Patients with SCA displayed a 10-fold increase in levels of MP derived from red blood cell (RBC) and platelets (PLT) when compared to their healthy counterparts (p < 0.0001). Splenectomized patients with SCA have more pronounced levels of MPRBC and MPPLT, and remained elevated after several weeks of follow-up. Levels of MP were not significantly associated with spleen removal procedures, age, gender, clinical severity score, hydroxyurea therapy, hemoglobin F, and co-existence of glucose-6-phosphate dehydrogenase deficiency. Collectively, these results suggest that splenectomy affects circulating levels of MP regardless of the known SCA modifiers and correlates.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Sultan Qaboos University
ID : IG/MED/HAEM/11/01
Informations de copyright
© 2023 John Wiley & Sons Ltd.
Références
Kinger NP, Moreno CC, Miller FH, Mittal PK. Abdominal manifestations of sickle cell disease. Curr Probl Diagn Radiol. 2021;50:241-251.
El Hoss S, Brousse V. Considering the spleen in sickle cell disease. Expert Rev Hematol. 2019;12:563-573.
Al-Salem AH. Splenic complications of sickle cell anemia and the role of splenectomy. ISRN Hematol. 2011;2011:864257.
Wali YA, Al-Lamki Z, Hussein SS, et al. Splenic function in Omani children with sickle cell disease: correlation with severity index, hemoglobin phenotype, iron status, and alpha-thalassemia trait. Pediatr Hematol Oncol. 2002;19:491-500.
Jana S, Strader MB, Meng F, et al. Hemoglobin oxidation-dependent reactions promote interactions with band 3 and oxidative changes in sickle cell-derived microparticles. JCI Insight. 2018;3:e120451.
Camus SM, De Moraes JA, Bonnin P, et al. Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease. Blood. 2015;125:3805-3814.
Hebbel RP, Key NS. Microparticles in sickle cell anaemia: promise and pitfalls. Br J Haematol. 2016;174:16-29.
Enjeti AK, Lincz LF, Seldon M. Microparticles in health and disease. Semin Thromb Hemost. 2008;34:683-691.
Ferraris VA. Microparticles: the good, the bad, and the ugly. J Thorac Cardiovasc Surg. 2015;149:312-313.
Ball S, Nugent K. Microparticles in hematological malignancies: role in coagulopathy and tumor pathogenesis. Am J Med Sci. 2018;355:207-214.
van Tits LJ, van Heerde WL, Landburg PP, et al. Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis. Biochem Biophys Res Commun. 2009;390:161-164.
Van Beers EJ, Schaap MC, Berckmans RJ, et al. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica. 2009;94:1513-1519.
Tantawy AA, Adly AA, Ismail EA, Habeeb NM, Farouk A. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: relation to cardiovascular complications. Platelets. 2013;24:605-614.
Shet AS, Aras O, Gupta K, et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood. 2003;102:2678-2683.
Piccin A, Murphy C, Eakins E, et al. Circulating microparticles, protein C, free protein S and endothelial vascular markers in children with sickle cell anaemia. J Extracell Vesicles. 2015;4:28414.
Nebor D, Romana M, Santiago R, et al. Fetal hemoglobin and hydroxycarbamide modulate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children. Haematologica. 2013;98:862-867.
Nebor D, Bowers A, Connes P, et al. Plasma concentration of platelet-derived microparticles is related to painful vaso-occlusive phenotype severity in sickle cell anemia. PLoS One. 2014;9:e87243.
Marsh A, Schiffelers R, Kuypers F, et al. Microparticles as biomarkers of osteonecrosis of the hip in sickle cell disease. Br J Haematol. 2015;168:135-138.
Kasar M, Boğa C, Yeral M, Asma S, Kozanoglu I, Ozdogu H. Clinical significance of circulating blood and endothelial cell microparticles in sickle-cell disease. J Thromb Thrombolysis. 2014;38:167-175.
Gerotziafas GT, Van Dreden P, Chaari M, et al. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles. Thromb Haemost. 2012;107:1044-1052.
Brunetta DM, De Santis GC, Silva-Pinto AC, Oliveira de Oliveira LC, Covas DT. Hydroxyurea increases plasma concentrations of microparticles and reduces coagulation activation and fibrinolysis in patients with sickle cell anemia. Acta Haematol. 2015;133:287-294.
Garnier Y, Ferdinand S, Etienne-Julan M, et al. Differences of microparticle patterns between sickle cell anemia and hemoglobin SC patients. PLoS One. 2017;12:e0177397.
Olatunya OS, Lanaro C, Longhini AL, et al. Red blood cells microparticles are associated with hemolysis markers and may contribute to clinical events among sickle cell disease patients. Ann Hematol. 2019;98:2507-2521.
Dembélé AK, Lapoumeroulie C, Diaw M, et al. Cell-derived microparticles and sickle cell disease chronic vasculopathy in sub-Saharan Africa: a multinational study. Br J Haematol. 2021;192:634-642.
Garnier Y, Ferdinand S, Garnier M, et al. Plasma microparticles of sickle patients during crisis or taking hydroxyurea modify endothelium inflammatory properties. Blood. 2020;136:247-256.
Zahran AM, Elsayh KI, Saad K, et al. Circulating microparticles in children with sickle cell anemia in a tertiary Center in Upper Egypt. Clin Appl Thromb Hemost. 2019;25:1076029619828839.
Boulassel MR, Al-Naamani A, Al-Zubaidi A, et al. Coexistence of sickle cell disease and systemic lupus erythematosus is associated with quantitative and qualitative impairments in circulating regulatory B cells. Hum Immunol. 2022;83:818-825.
Lenti MV, Luu S, Carsetti R, et al. Asplenia and spleen hypofunction. Nat Rev Dis Primers. 2022;8:71.
Pattanapanyasat K, Gonwong S, Chaichompoo P, et al. Activated platelet-derived microparticles in thalassaemia. Br J Haematol. 2007;136:462-471.
Agouti I, Cointe S, Robert S, et al. Platelet and not erythrocyte microparticles are procoagulant in transfused thalassaemia major patients. Br J Haematol. 2015;171:615-624.
Kheansaard W, Phongpao K, Paiboonsukwong K, Pattanapanyasat K, Chaichompoo P, Svasti S. Microparticles from β-thalassaemia/HbE patients induce endothelial cell dysfunction. Sci Rep. 2018;8:13033.
Campello E, Zabeo E, Radu CM, et al. Dynamics of circulating microparticles in obesity after weight loss. Intern Emerg Med. 2016;11:695-702.
Noulsri E, Lerdwana S, Palasuwan D, Palasuwan A. Cell-derived microparticles in blood products from Thalassemic blood donors. Lab Med. 2021;52:150-157.
Nantakomol D, Palasuwan A, Chaowanathikhom M, Soogarun S, Imwong M. Red cell and platelet-derived microparticles are increased in G6PD-deficient subjects. Eur J Haematol. 2012;89:423-429.
Morikis VA, Hernandez AA, Magnani JL, Sperandio M, Simon SI. Targeting neutrophil adhesive events to address Vaso-occlusive crisis in sickle cell patients. Front Immunol. 2021;12:663886.
Boulassel MR, Al-Zubaidi A, Al-Zadjali S, et al. Elevated levels of circulating invariant natural killer cell subsets are skewed toward Th2-like phenotype in children with sickle cell disease. Clin Immunol. 2020;210:108308.